Tuesday, July 15, 2025 8:29:57 AM
Less than 5% chance that the approval comes in September given how the minions are positioning and what we have seen in the public domain in terms of responses from MHRA, NICE, and posture (including details from 10-K in March, lack of ongoing commercial preparation, hiring) from NWBO.
It wouldn’t be surprising if we do not see approval this year. The minions are already pivoting towards Direct as the next big thing, LOL! So they are pushing L under the rug.
The highest likelihood (say 85%) is that they received major RFIs in Q1, 2025, or before. We could trace back to the last report from NWBO when they started putting the language that no interim updates will be provided by the company until the final decision on the application has been made. I think they added this language in their reports starting sometimes in the mid to second half of last year. They received major RFI just before then and haven’t been able to respond to all those concerns satisfactorily yet.
19-20 months for an application review and decision is extremely abnormal. So the chances of UK approval appear extremely low. No wonder minions are pivoting towards Direct now.
It wouldn’t be surprising if we do not see approval this year. The minions are already pivoting towards Direct as the next big thing, LOL! So they are pushing L under the rug.
The highest likelihood (say 85%) is that they received major RFIs in Q1, 2025, or before. We could trace back to the last report from NWBO when they started putting the language that no interim updates will be provided by the company until the final decision on the application has been made. I think they added this language in their reports starting sometimes in the mid to second half of last year. They received major RFI just before then and haven’t been able to respond to all those concerns satisfactorily yet.
19-20 months for an application review and decision is extremely abnormal. So the chances of UK approval appear extremely low. No wonder minions are pivoting towards Direct now.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
